FDA Inspection 909759 — Pharmaceutica North America, Inc.

Pharmaceutica North America, Inc. — FEI 3008789867

The FDA completed an inspection of Pharmaceutica North America, Inc. on Jan 6, 2015 in Glendale, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 5 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jan 6, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Glendale, CA (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
364121 CFR 211.204Record information inclusions
434021 CFR 211.142Written warehousing procedures established/followed
434221 CFR 211.142(b)Storage under appropriate conditions
438921 CFR 211.198(a)Procedures to be written and followed